期刊文献+

UPLC-MS/MS测定猪肉中头孢类药物的残留量

Determination of Cephalosporin Residues in Pork by UPLCMS/MS
下载PDF
导出
摘要 本文采用超高效液相色谱-串联质谱对猪肉中头孢类药物残留量进行分析。样品经乙腈-水溶液和磷酸盐缓冲溶液提取,HLB固相萃取柱纯化后用超高效液相色谱质谱联用仪进行测定。结果表明,3种头孢类药物浓度在0~200 ng·mL^(-1)时,相关系数大于0.996,线性关系良好;检出限为0.001~0.365μg·kg^(-1),定量限为0.003~1.220μg·kg^(-1)。不同浓度下样品的加标回收率为83.2%~95.2%,相对标准偏差为1.9%~7.5%,标准偏差为0.078~2.817μg·kg^(-1)。 This article uses ultra high performance liquid chromatography tandem mass spectrometry to analyze the residual levels of cephalosporins in pork.The sample was extracted by acetonitrile aqueous solution and phosphate buffer solution,purified by HLB solid-phase extraction column,and determined by ultra-high performance liquid chromatography mass spectrometry.The results showed that the correlation coefficient(R2)of the three cephalosporin drugs was greater than 0.996 within 0~200 ng·mL^(-1),indicating a good linear relationship;the detection limit is 0.001~0.365μg·kg^(-1),with a quantification limit is 0.003~1.220μg·kg^(-1).The spiked recovery rates of samples at different concentrations is 83.2%~95.2%,with a relative standard deviation is 1.9%~7.5%and a standard deviation is 0.078~2.817μg·kg^(-1).
作者 孙钰莹 李启卉 陈月 SUN Yuying;LI Qihui;CHEN Yue(National Light Industry Food Quality Supervision and Testing of the Nanjing Station,Nanjing 211816,China)
出处 《食品安全导刊》 2024年第7期110-113,共4页 China Food Safety Magazine
关键词 猪肉 头孢类药物 超高效液相色谱-串联质谱 固相萃取柱 pork cephalosporins ultra performance liquid chromatography tandem mass spectrometry solid-phase extraction column
  • 相关文献

参考文献4

二级参考文献31

  • 1张致平.抗生素结构修饰的进展[J].中国抗生素杂志,2006,31(2):90-99. 被引量:9
  • 2刘家健.头孢菌素类品种研发与生产现状探讨[J].中国抗生素杂志,2006,31(2):100-106. 被引量:16
  • 3Jack J C, Theresa M B, Joseph T W, et al. Randomized, prospective comparison of first-and second-generation cephalosporins as infection prophylaxis for cardiac surgery[J]. Am JSurg, 1993, 166(6): 734-737.
  • 4Stuart M H. Pharmacokinetics of the third-generation cephalosporins[J]. Am J Med, 1985, 79(2): 21-24.
  • 5Emirhan N, Sedef K, Doruk K, et al. Simultaneous roultiresponse optimization of an HPLC method to separate seven cephalosporins in plasma and amniotic fluid: Application to validation and quantification of cefepime, cefixime and cefoperazone[J]. Talanta, 2009, 80(1): 117-126.
  • 6Yoshizawa H, Kubota T, Itani H, et al. New broad-spectrum parenteral cephalosporins exhibiting potentactivity against both methicillin-resistant Staphylococcus aureus(MRSA ) and Pseudomonas aeruginosa. Part 2: Synthesis and Structure-activity relationships in the S-3578 series[J]. Bioorg Med Chem, 2004, 12:4211-4219.
  • 7Gasink L B, Fishrnan N O, Weiner M G, et al. Fluoroquinolone- resistant Pseudomonas aeruginosa: assessment of risk factors and clinical impact[J]. Am JMed, 2006, 119(6): 526.
  • 8Tomoyasu I, Shohei H, Yuj I. Phosphonocephem derivatives, process for the preparation of the same and use thereof [P]. US 6417175 B1, 2006-07-09.
  • 9Wiseman L R, Lamb H M. Cefpirome: a review of its antibacterial activity, pharmacokinetic properties and clinical efficacy in the treatment of severe nosocomial infections and febrile neutropenia [J]. Drugs, 1997, 54:117-140.
  • 10SUHREN G, KNAPPSTEINK. Detection of cefquinome in milk by liquid chromatography and screening methods[J]. Analytica Chimica Acta, 2003, 483(1): 363-372.

共引文献103

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部